These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8363271)

  • 1. Autoantibodies against cytochromes P-450 in drug-induced autoimmune hepatitis.
    Beaune PH; Bourdi M
    Ann N Y Acad Sci; 1993 Jun; 685():641-5. PubMed ID: 8363271
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.
    Boitier E; Beaune P
    Clin Rev Allergy Immunol; 2000 Apr; 18(2):215-39. PubMed ID: 10944706
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytochromes P450 as targets to autoantibodies in immune mediated diseases.
    Boitier E; Beaune P
    Mol Aspects Med; 1999; 20(1-2):84-137. PubMed ID: 10575654
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of heterologous expression systems to study autoimmune drug-induced hepatitis.
    Lecoeur S; Gautier JC; Belloc C; Gauffre A; Beaune PH
    Methods Enzymol; 1996; 272():76-85. PubMed ID: 8791764
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
    Bourdi M; Gautier JC; Mircheva J; Larrey D; Guillouzo A; Andre C; Belloc C; Beaune PH
    Mol Pharmacol; 1992 Aug; 42(2):280-5. PubMed ID: 1513326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of drug-induced hepatitis. A consequence of superposition of two xenobiotic systems].
    Pessayre D
    Gastroenterol Clin Biol; 1995; 19(5 Pt 2):B47-56. PubMed ID: 8522102
    [No Abstract]   [Full Text] [Related]  

  • 8. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
    Obermayer-Straub P; Strassburg CP; Manns MP
    Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9.
    Lecoeur S; André C; Beaune PH
    Mol Pharmacol; 1996 Aug; 50(2):326-33. PubMed ID: 8700140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis.
    Eliasson E; Stål P; Oksanen A; Lytton S
    J Hepatol; 1998 Nov; 29(5):819-25. PubMed ID: 9833921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
    Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis.
    Robin MA; Le Roy M; Descatoire V; Pessayre D
    J Hepatol; 1997; 26 Suppl 1():23-30. PubMed ID: 9138125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoimmune mechanisms and post-anesthetic hepatitis].
    Duheille J; Montagne P
    Ann Anesthesiol Fr; 1976; 17(3):327-34. PubMed ID: 1078522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytochrome P450 isoenzymes and liver-kidney microsome antibodies. An antigen-antibody relationship].
    Duclos-Vallée JC; Yamamoto AM; Cresteil D; Alvarez F
    Gastroenterol Clin Biol; 1993; 17(12):908-12. PubMed ID: 8125222
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies against cytochromes P450: role in human diseases.
    Beaune P; Pessayre D; Dansette P; Mansuy D; Manns M
    Adv Pharmacol; 1994; 30():199-245. PubMed ID: 7833293
    [No Abstract]   [Full Text] [Related]  

  • 16. Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis.
    Belloc C; Gauffre A; André C; Beaune PH
    Pharmacogenetics; 1997 Jun; 7(3):181-6. PubMed ID: 9241657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemoline-induced autoimmune hepatitis.
    Sterling MJ; Kane M; Grace ND
    Am J Gastroenterol; 1996 Oct; 91(10):2233-4. PubMed ID: 8855756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cytochrome P450 autoantibodies in drug-induced disease.
    Beaune PH; Lecoeur S; Bourdi M; Gauffre A; Belloc C; Dansette P; Mansuy D
    Eur J Haematol Suppl; 1996; 60():89-92. PubMed ID: 8987248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal hepatitis associated with isoflurane exposure and CYP2A6 autoantibodies.
    Martin JL; Keegan MT; Vasdev GM; Nyberg SL; Bourdi M; Pohl LR; Plevak DJ
    Anesthesiology; 2001 Aug; 95(2):551-3. PubMed ID: 11506133
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
    Bourdi M; Larrey D; Nataf J; Bernuau J; Pessayre D; Iwasaki M; Guengerich FP; Beaune PH
    J Clin Invest; 1990 Jun; 85(6):1967-73. PubMed ID: 2347920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.